ARCHIVES

Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 7 | July 25, 2008

Download PDF Visit The Full Archive

Related Articles

Budget Projections for 1978 Offer Clues On Research NCI Hopes To Fund

June 18, 1976

Senate Passes NIH Reauthorization 87-10; $2.5 Bil. Auhtority For NCI, New Line Items

April 10, 1992

First Phase 0 Oncology Trial Demonstrates Effectiveness Of New Drug On Its Target

April 24, 2009

Editorial: Ambiance Through Exclusion

May 20, 1994

North Central Group Review Postponed While New Committee Formed To Handle All “Regional: Groups

July 10, 1981

NCI Programs: Institute Partners With Two Groups On Psychosocial Issues

May 16, 1997